| Detected | Trial | Change |
|---|---|---|
| 2026-05-21 | NCT02890355 FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients… |
Trial completed |
| 2026-05-21 | NCT02890355 FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients… |
date change Completion moved earlier: 2026-03-17 -> 2021-10-21 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT02152982 | Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed… | Glioblastoma | Active, Not Recruiting |
| Phase 2 | |||
| NCT01042379 | I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | Breast Neoplasms | Recruiting |
| NCT03289910 | Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT01638546 | Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory… | Recurrent Lung Small Cell Carcinoma | Active, Not Recruiting |
| NCT03581292 | Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed… | Anaplastic Astrocytoma | Active, Not Recruiting |
| NCT01585805 | Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in… | Locally Advanced Pancreatic Adenocarcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT01012817 | Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or… | Metastatic Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT01386385 | Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With… | Lung Adenocarcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT00740805 | Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With… | Ann Arbor Stage III Non-Hodgkin Lymphoma | Active, Not Recruiting |
| NCT01351909 | Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic… | Locally Advanced Unresectable Breast Carcinoma | Active, Not Recruiting |
| NCT01366144 | Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are… | Breast Carcinoma | Active, Not Recruiting |
| NCT01434316 | Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors | Advanced Malignant Solid Neoplasm | Active, Not Recruiting |
| NCT01251874 | Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer | Recurrent Breast Carcinoma | Active, Not Recruiting |